A Phase II Trial of Neoadjuvant Gemcitabine/nab-Paclitaxel and SBRT for Potentially Resectable Pancreas Cancer: an Evaluation of Acute Toxicity.
Journal of clinical oncology(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of clinical oncology(2018)